Brief: Medivir To Collaborate With Eisai

Medivir AB

04/11/2024 07:36

Nov 4 (Reuters) - Medivir AB  MEDIVIR.ST :
    * ANNOUNCES NEW CLINICAL TRIAL COLLABORATION AND SUPPLY
AGREEMENT
WITH EISAI TO EVALUATE FOSTROX IN COMBINATION WITH LENVATINIB IN
ADVANCED LIVER CANCER
    * EISAI TO PROVIDE MULTIPLE RECEPTOR TYROSINE KINASE
INHIBITOR
LENVATINIB TO BE USED IN ALL STUDY ARMS
    * RETAINS FULL RIGHTS TO FOSTROX

Source text:  ID:nMFN99hJZp 
Further company coverage:  MEDIVIR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))